Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-08-14
2010-02-23
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S004100, C536S018100, C536S018400
Reexamination Certificate
active
07666848
ABSTRACT:
Novel thiophene glycoside derivatives of the formula Iin which the radicals have the stated meanings, and the physiologically tolerated salts thereof and processes for their preparation are disclosed. The compounds are suitable, for example, as antidiabetics.
REFERENCES:
patent: 5190923 (1993-03-01), Vincent et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6324512 (2001-11-01), Junqua et al.
patent: 6380230 (2002-04-01), Brodin et al.
patent: 0 462 884 (1991-12-01), None
patent: 1 213 296 (2002-06-01), None
patent: 1 277 736 (2003-01-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
J. Fuentes, et al., “Reactions of per-0-acetylglucosyl isothiocyanate with carbon bases. A new method for the stereocontrolled syntheses of nucleosides and glucosylaminothiophenes,” Tetrahedron: Asymmetry, 9:2517-32 (1998).
H. Okada, et al., “Synthesis and antitumor activities of prodrugs of benzoylphenylureas,” Chem. Pharm. Bull. 42(1) 57-61 (1994).
P. Tyle, “lontophoretic Devices for Drug Delivery,” Pharmaceutical Research, 3(6):318-26 (1986).
A. Asakawa, et al., “Cocaine-amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice,” Horm Metab Res, 33:554-58 (2001).
D. W. Lee, et al., “Leptin agonists as a potential approach to the treatment of obesity,” Drugs of the Future 26(9):873-81 (2001).
J. Salvador, et al., “Perspectives in the therapeutic use of leptin,” Expert Opinion on Pharmacotherapy, 1615-22 (2001).
H. J. F. Zunft, et al., “Carob pulp preparation for treatment of hypercholesterolemia,” Advances in Therapy, 8(5):230-36 (2001).
H. Fiesselmann, et al., Chem. Ber., 1907-13 (1956).
M. D. Mullican, et al., “Novel thiophene-, pyrrole-, furan-, and benzenecarboxamidotetrazoles as potential antiallergy agents,” J. Med. Chem., 34:2186-94 (1991).
G. M. Karp, et al., “Preparation of 4-hydroxy-2-trifluoromethylthiophene: A novel bioisostere of α, α, α-trifluoro-m-cresol,” Synthesis, 8:1078-80 (2000).
Derwent abstract for PCT application publication No. WO 01/83451.
Derwent abstract for PCT application publication No. WO 99/15525.
Derwent abstract for European application No. EP 0 462 884.
Fouda, Hassan G. et al., “Disposition and Metabolism of Tenidap in the Rat,” Drug Metabolism and Disposition, 25(2):140-148 (1997).
Brummerhop Harm
Frick Wendelin
Glombik Heiner
Heuer Hubert
Kramer Werner
Kurys Barbara E.
Peselev Elli
Sanofi-Aventis Deutschland GmbH
LandOfFree
Thiophene glycoside derivatives, processes for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophene glycoside derivatives, processes for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene glycoside derivatives, processes for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161147